Medical condition
Psoriatic Arthritis
Psoriatic Arthritis is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- leflunomide (APO-LEFLUNOMIDE) Antineoplastic and immunomodulating agents (L04)
- apremilast (OTEZLA) Antineoplastic and immunomodulating agents (L04)
- tofacitinib (XELJANZ) Antineoplastic and immunomodulating agents (L04)
- upadacitinib (RINVOQ) Antineoplastic and immunomodulating agents (L04)
- etanercept (BRENZYS) Antineoplastic and immunomodulating agents (L04)
- guselkumab (TREMFYA) Antineoplastic and immunomodulating agents (L04)
- ixekizumab (TALTZ) Antineoplastic and immunomodulating agents (L04)
- golimumab (SIMPONI) Antineoplastic and immunomodulating agents (L04)
- baricitinib (OLUMIANT) Antineoplastic and immunomodulating agents (L04)
- abatacept (ORENCIA) Antineoplastic and immunomodulating agents (L04)
- secukinumab (COSENTYX) Antineoplastic and immunomodulating agents (L04)
- methotrexate (ARX-METHOTREXATE) Antineoplastic and immunomodulating agents (L04)
